Biomarkers Europe 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences
Liquid biopsy and MRD at Biomarkers Europe 2026
Oct 13–14, 2026 Basel, Switzerland ~1k attendees Website
11 organizations at Biomarkers Europe 2026 present work in liquid biopsy & MRD: 6 technology and service providers, 4 academic, government and non-profit bodies and 1 drug developer. Between them they bring 15 presentations to the program. Most represented: Diagenode, European Institute of Oncology (IEO) and Brunel University of London. As of Oct 8, 2026.
Format
Top represented
Showing 1–11 of 11 organizations
| Organization | Biomarkers Europe 2026 Attendance |
|---|---|
Diagenode Liège, Belgium | ◇Bronze Sponsor |
Epigenomics company, part of Hologic, offering methylation profiling and bioinformatics services for biomarker discovery, including liquid biopsy and MRD studies. | Talk Tue Oct 13 3:45pm–4:10pm Epigenomics At 360° In Liquid Biopsy: Approaches And Case Studies For Biomarker Discovery And Drug Development Liquid biopsy & MRDGenomics, proteomics and multi-omics |
European Institute of Oncology (IEO) Milan, Italy | |
Cancer research hospital in Milan providing oncology care, research and education. | Panel Wed Oct 14 8:05am–8:30am Artificial Intelligence In Pathology And Biomarker Testing Multimodal & AI-enabled precision medicineDigital pathology & spatial biomarkers Talk Wed Oct 14 9:10am–9:35am The Evolving Role Of Pathology In Precision Oncology Digital pathology & spatial biomarkers Panel Wed Oct 14 3:15pm–3:40pm Optimising Liquid Biopsy, MCED And MRD For Clinical Decision-Making Liquid biopsy & MRD |
Brunel University of London London, UK | |
Public research university in Uxbridge, west London. | Talk Tue Oct 13 12:15pm–12:40pm Enumeration And Characterisation Of Circulating Tumour Cells Using Imaging Flow Cytometry And Artificial Intelligence (AI) Liquid biopsy & MRDMultimodal & AI-enabled precision medicine Panel Wed Oct 14 8:05am–8:30am Quantum Computing For Biomarker Discovery Multimodal & AI-enabled precision medicineBiomarker discovery & translation |
Royal Brompton & Harefield Hospitals London, UK | |
Specialist heart and lung hospitals in London, part of Guy's and St Thomas' NHS Foundation Trust. | Talk Tue Oct 13 12:15pm–12:40pm Enumeration And Characterisation Of Circulating Tumour Cells Using Imaging Flow Cytometry And Artificial Intelligence (AI) Liquid biopsy & MRDMultimodal & AI-enabled precision medicine Panel Wed Oct 14 8:05am–8:30am Quantum Computing For Biomarker Discovery Multimodal & AI-enabled precision medicineBiomarker discovery & translation |
Velindre University NHS Trust Cardiff, UK | |
Welsh NHS trust running the Velindre Cancer Service and the Welsh Blood Service. | Panel Tue Oct 13 1:05pm–1:30pm Translating Biomarkers From Discovery To Clinical Use Biomarker discovery & translation Talk Wed Oct 14 3:40pm–4:05pm Liquid Biopsy In Cancer Pathways - Welsh Perspective Liquid biopsy & MRD |
BD Franklin Lakes, NJ | ◆Gold Sponsor |
Global medical technology company making products for medical discovery, diagnostics and care delivery, including blood collection and sample handling. | Talk Wed Oct 14 9:35am–10:00am Strategies For Preserving Valuable Biomarkers In Blood Biomarker discovery & translation |
Methylomics Rijswijk, Netherlands | ◇Bronze Sponsor |
Offers MeD-seq genome-wide DNA methylation profiling as a service and develops methylation tests for cervical, endometrial and lung cancers. | Talk Wed Oct 14 12:10pm–12:35pm Towards Scalable Methylation Profiling for Biomarker Discovery and Clinical Monitoring Genomics, proteomics and multi-omicsBiomarker discovery & translation |
Mission Bio South San Francisco, CA | ◇Bronze Sponsor |
Makes the Tapestri platform for single-cell multi-omics, used in cancer research, cell and gene therapy and AML residual disease monitoring. | Talk Tue Oct 13 3:45pm–4:10pm From Single Cell Data to Breakthrough Therapies Genomics, proteomics and multi-omics |
Boehringer Ingelheim Ingelheim, Germany | |
Family-owned pharmaceutical company developing human and animal health medicines, including cardiometabolic, respiratory, oncology and mental health drugs. | Talk Tue Oct 13 11:50am–12:15pm Liquid Biopsy Approaches Using Urinary Biomarkers In CKD Drug Development Liquid biopsy & MRDBiomarker discovery & translation |
RareCyte Seattle, Washington | ◇Bronze Sponsor |
Makes the Orion high-plex spatial proteomics platform and CyteFinder systems for finding and characterizing rare circulating cells in blood. | Talk Tue Oct 13 3:20pm–3:45pm From ROI to Whole-Slide Spatial Biology: Practical Evaluation of the Orion Platform After 5 Months Digital pathology & spatial biomarkers |
Precursion Huningue, France | ○Network & Programme Sponsor |
Multi-omics contract research organization, formerly Firalis Molecular Precision, offering biobanking, sequencing, ctDNA, proteomics and bioinformatics for biomarker studies. | Sponsor In the meeting’s sponsor directory, with no session on the public program |
Instantly find 20 buyers in liquid biopsy & MRD
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Browse Biomarkers Europe 2026 by
Organization type
Topic
Everyone
Not affiliated with or endorsed by Biomarkers, CDx & Precision Medicine or its organizers. Submit a correction